Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2025

Apr 4, 2025

32324_dirs_2025-04-04_a3903bb5-2f22-4c18-a6c4-518aa932548f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2024-12-07

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-07 Common Stock M 1196 Acquired 33545 Direct

Footnotes

F1: On December 10, 2024, the reporting person timely filed a Form 4, which inadvertently overstated in column 5 the number of shares of Iradimed Corporation (the "Issuer") common stock directly owned by the reporting person following the reported transaction. No transactions regarding the Issuer's securities were omitted. This inadvertent overstatement has been corrected in this amended filing.